
 [
{
"symbol" : "524731",
"exchange" : "BOM",
"id": "8666279",
"t" : "524731",
"e" : "BOM",
"name" : "Jenburkt Pharmaceuticals Ltd"
, "f_reuters_url" : "http:\u002F\u002Fstocks.us.reuters.com\u002Fstocks\u002Fratios.asp?rpc=66\u0026symbol=JENA.BO",
"f_recent_quarter_date" : "",
"f_annual_date" : "",
"f_ttm_date" : "",
"financials" :
[{
"f_type" : "Income\u0026nbsp\u003BStatement"
,"url" : "http:www.google.comfinance?fstype=ii&q=BOM:524731"
,"f_figures" :
[
]
},
{
"f_type" : "Balance\u0026nbsp\u003BSheet"
,"url" : "http:www.google.comfinance?fstype=bi&q=BOM:524731"
,"f_figures" :
[
]
},
{
"f_type" : "Cash\u0026nbsp\u003BFlow"
,"url" : "http:www.google.comfinance?fstype=ci&q=BOM:524731"
,"f_figures" :
[
]
}],
"kr_recent_quarter_date" : "Q4 (Dec \u002717)",
"kr_annual_date" : "2017",
"kr_ttm_date" : "TTM",
"keyratios" :
[
{
"title" : "Net profit margin",
"recent_quarter" : "14.71%",
"annual" : "13.08%",
"ttm" : "13.58%"
},
{
"title" : "Operating margin",
"recent_quarter" : "19.70%",
"annual" : "17.36%",
"ttm" : "17.19%"
},
{
"title" : "EBITD margin",
"recent_quarter" : "",
"annual" : "19.09%",
"ttm" : "18.59%"
},
{
"title" : "Return on average assets",
"recent_quarter" : "",
"annual" : "20.10%",
"ttm" : ""
},
{
"title" : "Return on average equity",
"recent_quarter" : "",
"annual" : "28.55%",
"ttm" : ""
},
{
"title" : "Employees",
"recent_quarter" : "600",
"annual" : "-",
"ttm" : "-"
}
]
, "c" : "+11.15",
"l" : "575.00",
"cp" : "1.98",
"ccol" : "chg",
"op" : "566.00",
"hi" : "575.15",
"lo" : "560.10",
"vo" : "3,014.00",
"avvo" : "",
"hi52" : "649.80",
"lo52" : "392.00",
"mc" : "2.63B",
"pe" : "17.51",
"fwpe" : "",
"beta" : "",
"eps" : "32.84",
"dy" : "1.41",
"ldiv" : "8.10",
"shares" : "4.59M",
"instown" : "",
"eo":""
, "related" : [
{
"id" : "8666279",
"name" : "Jenburkt Pharmaceuticals Ltd",
"t" : "524731",
"e" : "BOM",
"l" : "575.00",
"c" : "+11.15",
"mc" : "2.63B",
"cp" : "1.98",
"ccol" : "chg"
}
,
{
"id" : "13151881",
"name" : "Colinz Laboratories Ltd",
"t" : "531210",
"e" : "BOM",
"l" : "15.00",
"c" : "0.00",
"mc" : "68.56M",
"cp" : "0.00",
"ccol" : "chb"
}
,
{
"id" : "678392",
"name" : "Novartis India Limited",
"t" : "500672",
"e" : "BOM",
"l" : "621.60",
"c" : "+5.55",
"mc" : "15.26B",
"cp" : "0.90",
"ccol" : "chg"
}
,
{
"id" : "5391783",
"name" : "Cipla Ltd",
"t" : "CIPLA",
"e" : "NSE",
"l" : "589.50",
"c" : "-6.15",
"mc" : "475.86B",
"cp" : "-1.03",
"ccol" : "chr"
}
,
{
"id" : "16546949",
"name" : "Lincoln Pharmaceuticals Ltd",
"t" : "531633",
"e" : "BOM",
"l" : "239.25",
"c" : "+9.05",
"mc" : "4.77B",
"cp" : "3.93",
"ccol" : "chg"
}
,
{
"id" : "6355153",
"name" : "Sequent Scientific Limited",
"t" : "512529",
"e" : "BOM",
"l" : "83.50",
"c" : "+1.70",
"mc" : "20.53B",
"cp" : "2.08",
"ccol" : "chg"
}
,
{
"id" : "7222829",
"name" : "Makers Laboratories Ltd",
"t" : "506919",
"e" : "BOM",
"l" : "81.35",
"c" : "+1.15",
"mc" : "406.07M",
"cp" : "1.43",
"ccol" : "chg"
}
,
{
"id" : "14985096",
"name" : "Coral Laboratories Ltd",
"t" : "524506",
"e" : "BOM",
"l" : "591.00",
"c" : "+0.60",
"mc" : "2.11B",
"cp" : "0.10",
"ccol" : "chg"
}
,
{
"id" : "7853362",
"name" : "Shasun Chemicals \u0026 Drugs Limited",
"t" : "SHASUNPHAR",
"e" : "NSE",
"l" : "431.00",
"c" : "",
"mc" : "28.99B",
"cp" : "",
"ccol" : ""
}
,
{
"id" : "729147",
"name" : "Adinath Bio-Labs Limited",
"t" : "590088",
"e" : "BOM",
"l" : "0.30",
"c" : "",
"mc" : "66.22M",
"cp" : "",
"ccol" : ""
}
,
{
"id" : "317275294856362",
"name" : "Vaishali Pharma Ltd",
"c" : "",
"mc" : "",
"cp" : "",
"ccol" : ""
}
]
, "summary" : [{
"address": "Nirmala Apartments 93, Jayprakash Road,, Andheri (West), MUMBAI, 400058, India",
"phone": "+91-22-67603603",
"fax": "+91-22-66943123",
"url": "http:\u002F\u002Fwww.jenburkt.com\u002F",
"overview" : "Jenburkt Pharmaceuticals Limited is engaged in the manufacture of pharmaceutical formulations. The Company offers prescription and over-the-counter drugs. The Company offers pharmaceutical products for various therapeutic areas, including anthelmintic, anti-osteoporotic, anti-arthritic, antibiotics, aphrodisiac, dermatological, anti-diabetic, gastrointestinal, anti-hypertensive, hematinic, anti-inflammatory, analgesic, neuropathy, anti-malarial and protein preparation. Its pharmaceutical products include Ornel Tablets, Topcal-O Capsules, Pantazole Tablets, Rabera 20 Tablets, Efelac 100 Tablets, Efelac 200 Tablets, Numox Capsules, La-Viril Capsules, Triben Plus Cream, Ojen-Oz Tablets, Luma Tablets, Luma-Forte Tablets, Zenglobin Capsules and Nervijen P Capsules. Its healthcare products include Nocal Tablets, Nocal Sachet and Nocal Granular. The Company serves missionary hospitals and public sector enterprises, among others. Its manufacturing plant is located at Sihor, Gujarat."
} ]
, "management" : [
{
"name" : "Ashish U. Bhuta",
"title" : "Chairman of the Board, Managing Director"
}
,
{
"name" : "Ashish R. Shah",
"title" : "Compliance Officer, Company Secretary"
}
,
{
"name" : "Dilip H. Bhuta",
"title" : "Whole Time Director"
}
,
{
"name" : "Anjali Sunil Dalvi",
"title" : "Independent Director"
}
,
{
"name" : "Bharat V. Bhate",
"age" : "63",
"title" : "Non-Executive Independent Director"
}
,
{
"name" : "Arun Rangildas Raskapurwala",
"title" : "Non-Executive Independent Director"
}
,
{
"name" : "Rameshchandra J. Vora",
"title" : "Non-Executive Independent Director"
}
]
,"moreresources" : [
]
}]
